Bionano Genomics, Inc.
BNGO
$1.14
-$0.03-2.16%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 60.58% | 80.78% | 57.74% | 90.13% | 54.15% |
| Total Depreciation and Amortization | -2.49% | -57.27% | -20.01% | -18.74% | -32.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -87.91% | -95.15% | 149.56% | 17.70% | -45.28% |
| Change in Net Operating Assets | -86.96% | -184.66% | 82.50% | -61.83% | 132.39% |
| Cash from Operations | 35.81% | 55.53% | 83.38% | 90.17% | 78.16% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 33.77% | 13.13% | -93.11% | -129.54% | 105.49% |
| Cash from Investing | 33.77% | 13.13% | -93.09% | -129.56% | 105.41% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | 99.11% | -20.56% | 94.12% | 95.87% | 77.65% |
| Issuance of Common Stock | -73.95% | 27.96% | -74.60% | -13.72% | -40.52% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 84.11% | 61.55% | 98.36% | -138.08% | 94.07% |
| Cash from Financing | -58.79% | 67.35% | 174.27% | 150.38% | -94.32% |
| Foreign Exchange rate Adjustments | 275.00% | -37.50% | -2,300.00% | 65.38% | -108.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 281.00% | 96.07% | -101.11% | -171.72% | 102.28% |